Novel acromegaly screening system and screening method thereof

Abstract

The invention discloses a novel acromegaly screening system and a screening method thereof. The system comprises a pituitary adenoma intelligent health management platform, a hand feature database andan artificial intelligence early screening system; the pituitary adenoma intelligent health management platform is used for collecting hand photos of a to-be-tested person. the pituitary adenoma intelligent health management platform stores the collected hand photos in a hand feature database; the artificial intelligence early screening system comprises a convolutional neural network; the convolutional neural network carries out artificial intelligence deep learning on the hand photos in the hand feature database, so that a deep learning model is established, operation is carried out, and repeated verification and correction and data classification are carried out; and the artificial intelligence early screening system performs artificial intelligence background measurement and calculation on the hand photos, then outputs screening data, and preliminarily determines whether the patient is acromegaly patient or not according to the screening data; The novel acromegaly screening systemis low in cost and high in efficiency, replaces hematology / nuclear magnetic resonance examination and the like, and effectively reduces investment of manpower and material resources for screening.

Description

technical field [0001] The invention relates to the technical field of medical devices, in particular to a novel acromegaly screening system and a screening method thereof. Background technique [0002] Pituitary adenoma is a common intracranial tumor, accounting for about 15% of intracranial tumors, and its incidence is on the rise in recent years. Pituitary growth hormone (GH) adenoma is a common functional pituitary adenoma, and adults present as acromegaly. Although pituitary acromegaly is a benign lesion, due to the enlargement of the tumor, it compresses the optic chiasm, normal pituitary gland, cavernous sinus and other structures, causing visual dysfunction, hypopituitarism, headache and other symptoms; at the same time, the tumor secretes excessive GH, Insulin-like growth factor 1 (Insulin-like growth factor 1, IGF-1) level increases, which can cause excessive growth of soft tissue, hypertrophy of internal organs such as heart, lung, liver and kidney, osteoarthriti...

AI Technical Summary

Problems solved by technology

However, the following problems still exist in the early screening of patients with acromegaly: 1) The cost of imaging MRI scans for patients with acromegaly is relatively high, which increases the burden on society and patients’ families. also lower

2) Diagnosis results are easily affected by subjective factors of doctors; due to the uneven level of medical care and the limited energy of excellent doctors, the proportion of misdiagnosis and missed diagnosis is too high

3) Patients with pituitary adenoma need to be followed up for life, and it is difficult for patients to complete regular MRI scans to judge the progress of the disease

Images